Measurement and verification of positron emitter nuclei generated at each treatment site by target nuclear fragment reactions in proton therapy
The purpose of this study is to verify the characteristics of the positron emitter nuclei generated at each treatment site by proton irradiation.
Proton therapy using a beam on-line PET system mounted on a rotating gantry port (BOLPs-RGp), which the authors developed, is provided at the National Cancer Center Kashiwa, Japan. BOLPs-RGp is a monitoring system that can confirm the activity distribution of the proton irradiated volume by detection of a pair of annihilation gamma rays coincidentally from positron emitter nuclei generated by the target nuclear fragment reactions between irradiated proton nuclei and nuclei in the human body. Activity is measured from a start of proton irradiation to a period of 200 s after the end of the irradiation. The characteristics of the positron emitter nuclei generated in a patient's body were verified by the measurement of the activity distribution at each treatment site using BOLPs-RGp.
The decay curves for measured activity were able to be approximated using two or three half-life values regardless of the treatment site. The activity of half-life value of about 2 min was important for a confirmation of the proton irradiated volume.
In each proton treatment site, verification of the characteristics of the generated positron emitter nuclei was performed by using BOLPs-RGp. For the monitoring of the proton irradiated volume, the detection of generated in a human body was important.
- 2, , and , “Proton dose monitoring with PET: Quantitative studies in Lucite,” Phys. Med. Biol. 41, 177–196 (1996).
- 3, , , , , , and , “On-line monitoring of radiotherapy beams: Experimental results with proton beams,” Med. Phys. 26(6), 992–1006 (1999).
- 4 and , “Potential application of PET in quality assurance of proton therapy,” Phys. Med. Biol. 45, N151–N156 (2000).
- 5, , , , , , , , , and , “Distributions of decayed nucleus produced from the target fragment reaction in and patient liver targets by using a proton beam for therapy,” in Abstracts of the XXXIV PTCOG Meeting, Boston, MA, 2001, pp. 15–16.
- 6, , and , “In-beam PET measurements of radioactivity induced by proton beams,” Phys. Med. Biol. 47, 21–36 (2002).
- 7, , , , , and , “Usefulness of positron-emission tomographic images after proton therapy,” Int. J. Radiat. Oncol., Biol., Phys. 53, 1388–1391 (2002).
- 8, , , , , , and , “Dose quantification from in-beam positron emission tomography,” Radiother. Oncol. 73, S96–S98 (2004).
- 9, , , , and , “Distributions of decayed nuclei generated in the and targets by the target nuclear fragment reaction using therapeutic MONO and SOBP proton beam,” Med. Phys. 32(4), 1070–1082 (2005).
- 10, , and , “Experimental study on the feasibility of in-beam PET for accurate monitoring of proton therapy,” IEEE Trans. Nucl. Sci. 52, 778–786 (2005).
- 11, , , and , “Dose-volume delivery guided proton therapy using beam on-line PET system,” Med. Phys. 33(11), 4190–4197 (2006).
- 12, , , , , , , and , “PET/CT imaging for treatment verification after proton therapy: A study with plastic phantoms and metallic implants,” Med. Phys. 34(2), 419–435 (2007).
- 13, , , , , , , , , , and , “Patient study of in vivo verification of beam delivery and range, using positron emission tomography and computed tomography imaging after proton therapy,” Int. J. Radiat. Oncol., Biol., Phys. 68(3), 920–934 (2007).
- 14, , , , , , , , and , “Experimental verification of proton beam monitoring in a human body by use of activity image of positron-emitting nuclei generated by nuclear fragmentation reaction,” Radiol. Phys. Technol. 1(1), 44–54 (2008).
- 15, , , , , and , “The development and clinical use of a beam on-line PET system mounted on a rotating gantry port in proton therapy,” Int. J. Radiat. Oncol., Biol., Phys. 76(1), 277–286 (2010).
- 16 ICRU, “ Photon, electron, proton and neutron interaction date for body tissues,” ICRU Report No. 46, 11–13 (1992).
- 17 NNDC, http://www.nndc.bnl.gov/.
- 18, , , , , , and , “A compact planar positron imaging system,” Nucl. Instrum. Methods Phys. Res. A 516, 564–574 (2004).
- 19 et al., “Washout studies of 11C in rabbit thigh muscle implanted by secondary beams of HIMAC,” Phys. Med. Biol. 48, 875–889 (2003).
- 20 et al., “Washout measurement of radioisotope implanted by radioactive beams in the rabbit,” Phys. Med. Biol. 48, 2269–2281 (2003).
- 21 et al., “In-beam PET measurements of biological half-lives of irradiation induced -activity,” Acta Oncol. (Madr) 47, 1077–1086 (2008).
- 22, , , , and , “Tissue perfusion rate determined from the decay of oxygen-15 activity after photon activation in situ,” Science 204(4398), 1215–1217 (1979).
- 23, , , and , “Photon activation-15O decay studies of tumor blood flow,” Med. Phys. 8, 324–336 (1981).
- 24 , , , , , , and , “In-beam PET imaging for the control of heavy-ion tumour therapy,” IEEE Trans. Nucl. Sci. 44, 1492–1498 (1997).
- 25, , , , , , and , “Charged hadron tumour therapy monitoring by means of PET,” Nucl. Instrum. Methods Phys. Res. A 525, 284–288 (2004).